SCHEMBL7818262

SCHEMBL7818262

CSCOc1cccc2c(N3CCc4ccccc4C3C)nc(Nc3ccc(F)cc3C)nc12

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
AXL P30530 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7820251 0.99 AXL (0.34) AXL
SCHEMBL7810482 0.92 MEN1 (0.35) AXL
Hydrochloric Acid SCHEMBL7825442 0.91 MEN1 (0.35) AXL
SCHEMBL7812669 0.89
SCHEMBL7810109 0.89
SCHEMBL7810103 0.89
SCHEMBL7811240 0.89
Hydrochloric Acid SCHEMBL7809766 0.88
Hydrochloric Acid SCHEMBL7809762 0.88
Hydrochloric Acid SCHEMBL7825393 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0677049-B1 QUINAZOLINE DERIVATIVES YUHAN CORP LTD (KR) 2001-07-25 EP claimed
EP-0677049-B1 QUINAZOLINE DERIVATIVES YUHAN CORP LTD (KR) 2001-07-25 EP disclosed
US-5686458-A Quinazoline deriviates for treating peptic ulcer YUHAN CORPORATION (KR) 1997-11-11 US disclosed